Search by Drug Name or NDC
NDC 50268-0772-13 Tranexamic Acid 650 mg/1 Details
Tranexamic Acid 650 mg/1
Tranexamic Acid is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvPAK. The primary component is TRANEXAMIC ACID.
MedlinePlus Drug Summary
Tranexamic acid is used to treat heavy bleeding during the menstrual cycle (monthly periods) in women. Tranexamic acid is in a class of medications called antifibrinolytics. It works to improve blood clotting.
Related Packages: 50268-0772-13Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Tranexamic Acid
Product Information
| NDC | 50268-0772 |
|---|---|
| Product ID | 50268-772_0e7601e7-a14f-644a-e063-6394a90a5f80 |
| Associated GPIs | |
| GCN Sequence Number | 066336 |
| GCN Sequence Number Description | tranexamic acid TABLET 650 MG ORAL |
| HIC3 | M9D |
| HIC3 Description | ANTIFIBRINOLYTIC AGENTS |
| GCN | 28578 |
| HICL Sequence Number | 002802 |
| HICL Sequence Number Description | TRANEXAMIC ACID |
| Brand/Generic | Generic |
| Proprietary Name | Tranexamic Acid |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Tranexamic Acid |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 650 |
| Active Ingredient Units | mg/1 |
| Substance Name | TRANEXAMIC ACID |
| Labeler Name | AvPAK |
| Pharmaceutical Class | Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE] |
| DEA Schedule | n/a |
| Marketing Category | NDA AUTHORIZED GENERIC |
| Application Number | NDA022430 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 50268-0772-13 (50268077213)
| NDC Package Code | 50268-772-13 |
|---|---|
| Billing NDC | 50268077213 |
| Package | 30 BLISTER PACK in 1 BOX (50268-772-13) / 1 TABLET in 1 BLISTER PACK (50268-772-11) |
| Marketing Start Date | 2022-09-16 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.51303 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | TRANEXAMIC ACID 650 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 6 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis